Patent ID: 8263645
Filing Date: 2012-09-11
Classification: A61K,A61M

Abstract:
1. A method for treating a patient afflicted with a pulmonary disease or condition selected from the group consisting of chronic obstructive pulmonary disease, allergic asthma, non-allergic asthma, wheezing, and any other inflammatory or allergic lung diseases, said method comprising the steps of: providing a volume of a pharmaceutically acceptable aqueous composition including disodium cromoglycate in dissolved form at a concentration of greater than 2 wt.-%; nebulizing the volume by a nebulizer into an aerosol, wherein the aerosol exhibits a fine particle fraction of at least 30% of droplets having a size less than 3.3 μm, and wherein the difference between the mass median aerodynamic diameter when measured at room temperature and at a relative humidity of about 50% and the mass median aerodynamic diameter when measured at room temperature and at a relative humidity of about 95% is less than 0.5 μm; and delivering said aerosol to the patient; wherein the fine particle fraction is defined as the percentage of aerosol droplets having a diameter of less than 3.3 μm.